Formoterol is more effective than salmeterol in suppressing neutrophil reactivity
Gregory R. Tintinger, Annette J. Theron, Helen C. Steel and 2 more
ERJ Open Research · 2015
doi:10.1183/23120541.00014-2015 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
The research question addressed in the current study was: do the long-acting β2-adrenoreceptor agonists (LABAs) formoterol (full agonist) and salmeterol (partial agonist) possess comparable suppressive effects on human neutrophils? Formoterol suppresses neutrophil reactivity in vitro ; in COPD, this may contribute to anti-inflammatory efficacy <http://ow.ly/Qr9fE>
Abstract licence: CC BY-NC
References21
21 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.